Researchers – National Data
Resources for National Data
Here you can find customized resources to help you learn more about national data for HPV vaccination.
Trends in Human Papillomavirus–Associated Cancers — United States, 1999–2015
Oropharyngeal squamous cell carcinoma is now the most common HPV-associated cancer. During 1999–2015 cervical carcinoma incidence rates decreased 1.6% per year, and oropharyngeal SCC incidence rates increased 2.7% per year among men and 0.8% per year among women.
Accelerating HPV Vaccine Uptake: Urgency for Action to Prevent Cancer
One in four people in the United States—nearly 80 million—are infected with at least one type of human papillomavirus (HPV), a group of viruses linked to multiple cancers and other diseases. This report provides concrete, targeted, and actionable recommendations—supported by evidence and input from key stakeholders—to address these barriers and achieve greater uptake of HPV vaccines by both boys and girls.
Understanding HPV Coverage
The latest HPV vaccination coverage estimates in the 2017 National Immunization Survey-Teen show that HPV vaccination rates are increasing as more adolescents are up to date on HPV vaccination. In 2017, roughly half (49 percent) of adolescents were up to date on the HPV vaccine, and 66 percent of adolescents ages 13-17 years received the first dose to start the vaccine series.